Mercodia
Mercodia is a Swedish biotech founded in 1991 that develops gold-standard immunoassays and provides GLP-compliant bioanalytical services for cardiometabolic drug development, serving pharmaceutical, biotech, and academic customers across 76+ countries.
- Company typePrivate
- Founded1991
- HeadquartersUppsala, Sweden
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Mercodia does
Mercodia is a privately held Swedish biotech company founded in 1991 in Uppsala by Erling Holmlund, formerly of Pharmacia Diagnostics. The company develops and manufactures gold-standard immunoassays—primarily ELISA kits and MBeads bead-based assays—for the quantification of cardiometabolic biomarkers including insulin, C-peptide, glucagon, GLP-1, GIP, oxidized LDL, Lp(a), proinsulin, and the more recently launched HNL Homodimer for sepsis research. Its portfolio spans human assays and species-specific kits for mouse, rat, bovine, canine, equine, ovine, and porcine models, complemented by proprietary control and buffer products, and is supported by patented biological assets such as the 4E6 monoclonal antibody underpinning the Oxidized LDL ELISA.
The company operates three revenue streams: (1) immunoassay kit sales distributed across 76+ countries via direct website sales, regional sales managers, and authorized distributors; (2) GLP-compliant bioanalytical services for preclinical and clinical studies—including PK/PD analysis, biomarker analysis across 500+ analytes, assay development, and immunogenicity testing; and (3) ISO 13485:2016 / MDSAP-certified contract manufacturing of reagents, buffers, and coated plates for life science partners. Bioanalytical services are delivered from labs in Uppsala, Sweden and Winston-Salem, North Carolina (established 2023), supporting FDA, EMA, and ICH regulatory workflows for pharmaceutical and biotechnology clients developing diabetes, obesity, and cardiovascular therapies.
Mercodia serves a horizontally segmented customer base spanning pharmaceutical/biotech drug developers, academic and research institutions, and veterinary diagnostics customers, with 9,997+ peer-reviewed publications citing its products and 190+ completed bioanalytical projects. The business has grown approximately 70% over the past three years and 33% in 2024, earning the Di Gasell business growth award from Dagens industri six consecutive times, and is led by CEO Jörgen Dahlström alongside CFO Mats Lundin, CCO Torben Thölix, and COO Jonas Hermansson.
Mercodia firmographics
Firmographics- Name
- Mercodia
- Legal name
- Mercodia Aktiebolag
- Website
- https://mercodia.com
- Company type
- Private
- Founded year
- 1991
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Mercodia is a Swedish biotech founded in 1991 that develops gold-standard immunoassays and provides GLP-compliant bioanalytical services for cardiometabolic drug development, serving pharmaceutical, biotech, and academic customers across 76+ countries.
- Ownership category
- akta.pro rank
Mercodia industry classification
Industry- Product category
- Immunoassay Kits
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Medical Laboratories (621511), Analytical Laboratory Instrument Manufacturing (334516)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071), Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Bioanalytical & PK/PD Sample Analysis (Trial Support) (HLAGAEAG)
- akta.pro secondary industries
- Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB), Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC), Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI), Clinical Chemistry & Immunoassay Systems (HLAHAAAA)
Keywords
Where Mercodia is headquartered
LocationHeadquarters
- HQ city
- Uppsala
- HQ country
- Sweden
- HQ region
- Europe
Offices2 records
Markets served
Mercodia business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure
Revenue model
- Immunoassay Product Sales: Sale of gold-standard ELISA kits and MBeads assays for cardiometabolic research. Products include insulin, C-peptide, glucagon, GLP-1, GIP, oxidized LDL, Lp(a), proinsulin, MPO, HNL Homodimer, and species-specific assays (mouse, rat, bovine, canine, equine, porcine, ovine).
- Bioanalytical Services: Contract research services for preclinical and clinical studies including PK/PD analysis, biomarker analysis, assay development, immunogenicity testing. Services provided from GLP-compliant laboratories in Sweden and USA.
- Contract Manufacturing: Custom production of assay kits, buffers, coated plates, and key components for life science industry partners. Manufacturing follows ISO 13485:2016 and MDSAP standards.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Standard ELISA kits - single and 10-pack formats |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels6 records
Mercodia product offering
Product offeringCore offering
Mercodia develops, manufactures, and sells gold-standard immunoassay kits (ELISA and MBeads platforms) for quantitative measurement of cardiometabolic biomarkers including insulin, C-peptide, glucagon, GLP-1, GIP, oxidized LDL, Lp(a), proinsulin, MPO, and HNL Homodimer across human and animal matrices. The company also provides GLP-compliant bioanalytical services (PK/PD, biomarker analysis, assay development, immunogenicity testing) from laboratories in Sweden and the US, and offers contract manufacturing of assay kits and components under ISO 13485:2016 and MDSAP standards.
Product overview
Mercodia offers a comprehensive portfolio of gold-standard immunoassays for cardiometabolic and metabolic disease research, combined with expert bioanalytical services and contract manufacturing solutions. The product portfolio includes over 40 distinct ELISA kits and MBeads assays spanning human, rat/mouse, and larger animal (bovine, canine, equine, ovine, porcine) applications, focused on cardiometabolic biomarkers including insulin, C-peptide, glucagon, GLP-1, GIP, glicentin, proinsulin, oxidized LDL, Lp(a), MPO, and HNL Homodimer. These are complemented by control products (Diabetes Antigen Controls, GLP-1 Control, Glucagon Control, Animal Insulin Control) and supplement products (Diabetes Sample Buffer). The services division provides GLP-compliant bioanalytical services including PK/PD analysis, biomarker analysis (500+ biomarkers), assay development, immunogenicity testing, and contract manufacturing of assay kits, buffers, and coated plates under ISO 13485:2016 and MDSAP standards.
Differentiator
Problem solved
Functional benefit
Products and services
- C-peptide ELISA High-quality immunoassay for specific quantification of human C-peptide in serum, plasma, or urine. CE/IVD labeled on selected markets. Measurement range: 100-4000 pmol/L.
- Ultrasensitive C-peptide ELISA High-quality immunoassay for specific quantification of low levels of human C-peptide in serum, plasma, or urine. Measurement range: 5-280 pmol/L with detection limit below 2.5 pmol/L.
- Total GIP ELISA Chemiluminescent immunoassay for quantitative determination of total GIP (glucose-dependent insulinotropic polypeptide) in human samples. Measures both active GIP(1-42) and inactive isoform GIP(3-42).
- Glicentin ELISA Highly specific, sensitive immunoassay for determination of human glicentin in serum, plasma, and cell culture media. No cross-reactivity to circulating proglucagon-derived gut peptides.
- Total GLP-1 ELISA Chemiluminescent immunoassay for quantitative determination of amidated glucagon-like-peptide-1 (GLP-1) in human plasma and serum. Validated according to CLSI, FDA, and EMA guidelines.
- Glucagon ELISA CE/IVD-labeled highly specific and sensitive immunoassay for measuring glucagon in plasma and serum. No cross-reactivity to glicentin, proglucagon 1-16, and glucagon 3-29.
- HNL Homodimer ELISA Immunoassay for specific quantification of human homodimeric Human Neutrophil Lipocalin (HNL) in EDTA plasma. Biomarker for sepsis monitoring and antibiotic response research with superior specificity over CRP and PCT.
- Insulin (Total) MBeads Assay High-throughput tool enabling high specificity results from small sample volumes. For measurement of insulin in conditioned media from perifusion experiments or in vitro cultures. Kit format: 5 x 96 wells or 1 x 384 wells.
- Ultrasensitive Insulin ELISA High quality immunoassay for specific quantification of low levels of human insulin in serum or plasma. Measurement range: 0.15-20 mU/L. Calibrated against 1st International Reference Preparation 66/304.
- Insulin ELISA High-quality ELISA for specific measurement of human insulin in serum or plasma. Measurement range: 3-200 mU/L. Available in 1-pack and 10-pack formats.
- Insulin MBeads Assay (Human) High-throughput tool for highly specific insulin measurement from minimal sample volumes (10 µL). Optimized for detecting human insulin in serum, conditioned media, cell lysates, and homogenates.
- Iso-Insulin ELISA Quantitative determination of human insulin in serum or plasma, measuring both endogenous and exogenous insulin including common and non-commercially available insulin analogues.
- Lispro NL-ELISA Chemiluminescent immunoassay for quantitative determination of insulin lispro. Optimized for pharma use with no cross-reactivity to endogenous insulin or other insulin analogs. Validated for human and pig samples.
- Lp(a) ELISA Solid phase two-site enzyme immunoassay for quantitative determination of human Lipoprotein(a) in serum or plasma. Calibrated against validated Lp(a) preparation.
- MPO ELISA High quality enzyme immunoassay for quantification of human myeloperoxidase (MPO) in serum and plasma. Marker for airway inflammation, atherosclerosis, and cardiovascular disease risk.
- Oxidized LDL ELISA Unique sandwich ELISA based on proprietary mouse monoclonal antibody 4E6 for quantification of oxidized low-density lipoproteins. Central biomarker in atherosclerosis and cardiovascular disease.
- Proinsulin ELISA Method for quantitative determination of human proinsulin in serum or plasma. Highly specific with no cross-reactivity to human insulin or C-peptide. Calibrated against IRR 84/611.
- Mouse Insulin ELISA Easy-to-use assay for mouse insulin with highly specific monoclonal antibodies. Measurement range: 0.2-6.5 µg/L. Low sample volume (10 µL with 5 µL protocol available).
- Bioanalytical Services Tailored bioanalytical services for preclinical to clinical studies, primarily for biologics/large molecules, biosimilars, peptides, and gene therapy products. Includes PK & PD analysis, biomarker analysis, assay development, and immunogenicity testing from GLP-compliant laboratories in Sweden and the US.
- Biomarker Analysis Biomarker analysis services covering 500+ biomarkers for preclinical and clinical studies in cardiometabolic disease research.
- PK & PD Analysis Pharmacokinetics and pharmacodynamics analysis services for drug development, providing data to support dosing and efficacy decisions.
- Immunogenicity Testing Immunogenicity testing services to assess immune responses to biologics and therapeutics, supporting regulatory submissions for large molecule drugs.
- Assay Development & Optimization Custom assay development and optimization services for specific biomarker and therapeutic analysis needs, leveraging 30+ years of immunoassay expertise.
- Contract Manufacturing Custom production of assay kits, buffers, coated plates, and key components for the life science industry. Manufacturing validated according to ISO 13485:2016 and MDSAP standards.
Quantifiable outcome
- 33% revenue growth in 2024, 70% total growth over 3 years
- +3 more outcomes
Companies that use Mercodia
Customer profileNamed customers10 records
Segments4 records
Ideal customer profiles4 records
Mercodia technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Mercodia partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and minor.
- Celtic Molecular DiagnosticscoreNew distribution partnership covering Botswana, Namibia, South Africa, Uganda, and Zambia. Celtic Molecular Diagnostics is a well-established supplier of high-quality laboratory solutions in the region, ensuring improved local availability of Mercodia's immunoassays and responsive customer support.
- AttanacoreMercodia and Attana entered a strategic collaboration to advance bioanalysis. The partnership combines Mercodia's bioanalytical expertise with Attana's technology to develop next-generation solutions for preclinical drug development.
- LablyticaminorListed as partner on services page with logo display.
- SYNLABminorListed as partner on services page with logo display.
- CTCminorListed as partner on services page with logo display.
Scale indicators9 records
Recent moves8 records
Expansion highlights6 records
Mercodia competitors and assessment
Company assessmentBroad incumbents
- Charles River Laboratories: Charles River is a large CRO providing preclinical and clinical bioanalytical services, including ligand binding assays and immunogenicity testing. It competes with Mercodia's bioanalytical services arm from a broader portfolio perspective.
- Sartorius AG: Sartorius is a major life sciences tools and bioprocessing company with an immunoassay and bioanalytical portfolio serving pharma and biotech. It is a broader incumbent with overlapping customer relationships in bioanalysis and bioprocess analytics.
- ICON plc: ICON is a top-tier global CRO with extensive bioanalytical and central lab capabilities serving pharma and biotech clinical trials. It competes with Mercodia's bioanalytical services for outsourced clinical sample analysis in cardiometabolic and other programs.
- Eurofins Scientific: Eurofins is a global leader in bioanalytical CRO services for pharma and biopharma, including PK/PD, immunogenicity, and biomarker analysis — overlapping with Mercodia's services business but at significantly greater scale and across broader therapeutic areas.
Direct peers
- Meso Scale Diagnostics: Meso Scale Diagnostics (MSD) is a direct competitor in high-sensitivity immunoassay platforms for biomarker analysis, serving pharmaceutical, biotech, and academic researchers with multiplexed electrochemiluminescence assays — closely comparable technology and customer base to Mercodia's ELISA and MBeads offerings.
- Bio-Techne: Bio-Techne is a major life sciences tools company offering ELISA kits, reagents, and assay development services across multiple therapeutic areas including metabolic disease. It competes directly with Mercodia in the immunoassay kit and protein biomarker space and serves overlapping pharma/biotech/academic customers.
- ALPCO Diagnostics: ALPCO Diagnostics specializes in immunoassays for metabolic disease research, including insulin, C-peptide, and GLP-1 ELISAs — directly competing with Mercodia's core cardiometabolic product line among academic and pharma researchers.
- Cisbio (Revvity): Cisbio, now part of Revvity, provides HTRF immunoassay technology and bioanalytical kits widely used in drug development for biomarker and PK/PD analysis. It is a direct competitor to Mercodia in pharma-facing ligand binding assays and bioanalytical workflows.
- Crystal Chem: Crystal Chem is a niche direct competitor offering ELISA kits for insulin and metabolic hormones in multiple species (mouse, rat, human). It targets the same academic and pharma research customers as Mercodia and overlaps substantially in product scope.
Emerging players
- Quanterix: Quanterix offers ultra-sensitive Simoa single-molecule immunoassay technology for biomarker detection. It competes with Mercodia's ultrasensitive ELISA line in research applications requiring extremely low detection limits, particularly in neurology and inflammation research.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Mercodia social profiles
Digital presenceMercodia compliance and trust
Trust signalCompliance10 records
Mercodia financial estimates
Financial estimateRevenue estimate
Valuation estimate
Mercodia leadership team
Management profileNumber of profiles
Profiles12 records
Mercodia funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Mercodia M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Mercodia
What does Mercodia do?
Mercodia develops, manufactures, and sells gold-standard immunoassay kits (ELISA and MBeads platforms) for quantitative measurement of cardiometabolic biomarkers including insulin, C-peptide, glucagon, GLP-1, GIP, oxidized LDL, Lp(a), proinsulin, MPO, and HNL Homodimer across human and animal matrices. The company also provides GLP-compliant bioanalytical services (PK/PD, biomarker analysis, assay development, immunogenicity testing) from laboratories in Sweden and the US, and offers contract manufacturing of assay kits and components under ISO 13485:2016 and MDSAP standards.
Is Mercodia a public or private company?
Mercodia is a private company. It is classified as unknown and is currently operating.
When was Mercodia founded?
Mercodia was founded in 1991. It employs 51 to 100 people.
Where is Mercodia based?
Mercodia is headquartered in Uppsala, Sweden, in the Europe region.
How does Mercodia make money?
Three revenue lines are on record. Immunoassay Product Sales are the primary driver. The others are bioanalytical Services and contract Manufacturing.
Who are Mercodia's main competitors?
Broad incumbents on record are Charles River Laboratories, Sartorius AG, ICON plc and Eurofins Scientific. Direct peers are Meso Scale Diagnostics, Bio-Techne, ALPCO Diagnostics, Cisbio (Revvity) and Crystal Chem. Quanterix is listed as an emerging player.
Does Mercodia have an API?
No public API is recorded for Mercodia.
What industry is Mercodia in?
Mercodia's product category is Immunoassay Kits. Its primary akta.pro industry code is HLAGAEAG, Bioanalytical & PK/PD Sample Analysis (Trial Support), with a secondary code of HLAGAEAB, Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry). Its NAICS code is 325413 and its SIC code is 2835.